Evidence map›Paper›PMID 35002010›Full record

ArticleArtificial intelligence review2022

Using artificial intelligence technology to fight COVID-19: a review.

Yong Peng, Enbin Liu, Shanbi Peng, Qikun Chen, Dangjian Li, Dianpeng Lian

Abstract read
In one paragraph

Article in Artificial intelligence review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review.Archives of computational methods in engineering : state of the art reviews · 2023
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong PengPetroleum Engineering School, Southwest Petroleum University, Chengdu, 610500 China.
Enbin LiuPetroleum Engineering School, Southwest Petroleum University, Chengdu, 610500 China.ORCID 0000-0002-8624-836X
Shanbi PengSchool of Civil Engineering and Geomatics, Southwest Petroleum University, Chengdu, 610500 China.
Qikun ChenSchool of Engineering, Cardiff University, Cardiff, CF24 3AA UK.
Dangjian LiPetroleum Engineering School, Southwest Petroleum University, Chengdu, 610500 China.
Dianpeng LianPetroleum Engineering School, Southwest Petroleum University, Chengdu, 610500 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In late December 2019, a new type of coronavirus was discovered, which was later named severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Since its discovery, the virus has spread globally, with 2,975,875 deaths as of 15 April 2021, and has had a huge impact on our health systems and economy. How to suppress the continued spread of new coronary pneumonia is the main task of many scientists and researchers. The introduction of artificial intelligence technology has provided a huge contribution to the suppression of the new coronavirus. This article discusses the main application of artificial intelligence technology in the suppression of coronavirus from three major aspects of identification, prediction, and development through a large amount of literature research, and puts forward the current main challenges and possible development directions. The results show that it is an effective measure to combine artificial intelligence technology with a variety of new technologies to predict and identify COVID-19 patients.

Indexed as

Artificial intelligenceBlockchainCloud computingCOVID-19Epidemic prevention and controlInternet of Things

Identifiers

PMID35002010
PMCPMC8720541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.